ePrints

Improvement in quality of life for cancer patients treated with epoetin alfa

Lookup NU author(s): Paddy Stevenson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Anaemia is a common complication of cancer and cancer therapies, and fatigue is one of the most common symptoms of anaemia, disrupting functional performance and reducing overall quality of life. The positive effects of treating renal patients with recombinant human erythropoietin are well documented. This case report series details the specific effects of fatigue on individual patients with cancer and their way of life, and describes their significant improvement in lifestyle following the reversal of anaemia using recombinant human erythropoietin, epoetin alfa.

Publication metadata

Author(s): Libretto SE, Barrett-Lee PJ, Gorst DW, Kaczmarski R, McAdam K, Stevenson P, Thomas R

Publication type: Article

Publication status: Published

Journal: European Journal of Cancer Care

Year: 2001

Volume: 10

Issue: 3

Pages: 183-191

ISSN (print): 0961-5423

ISSN (electronic): 1365-2354

Publisher: Wiley-Blackwell Publishing Ltd.

URL: http://dx.doi.org/10.1046/j.1365-2354.2001.00264.x

DOI: 10.1046/j.1365-2354.2001.00264.x

Altmetrics

Share